The Neuro-SysMed Research School in Translational Neuroscience (RSTN) is established in March 2021, and will be official launched during spring, and is part of the neuro-scientific research environment at Neuro-SysMed. The research School offers education for ph.d- students, and the aim is to provide students with insights into groundbreaking translational neuro-science, and being an important supplement to the established educational program in research at K1, University of Bergen. Our main vision is to provide sustainable networks of researchers and support in order to encourage young researchers to expand their promising career beyond accomplished doctoral thesis. The RSTN is directed by Associate Professor Nina Grytten Torkildsen in collaboration with Professor Kjell-Morten Myhr, director, and Professor Charalompos Tzoulis, co-director at Neuro-Sysmed.
An interdisciplinary collaboration with cancer researchers at Centre for Cancer Biomarkers – CCBIO, has made opportunities for the establishment of our first three common ph.d- courses, which will be available for participation during autumn 2021. This collaboration will proceed and additional courses will be launched during 2022.
The RSTN will also plan for future establishment of courses and seminars at the scientific environment at Neuro-SysMed, involving junior scientist symposia and seminars related to the disciplines represented at Neuro-SysMed: Multiple Sclerosis (MS), Amyotrofic Lateral Sclerosis (ALS), Parkinson`s disease, dementia, cell models, metabolomics, biomarkers, informatics, drug screening, registry and epidemiology, care, scientific theory, suffering.
The RSNT aims at providing ph.d- students with relevant courses to fulfill obligatory credit points for the PhD training program at the University of Bergen. Another important objective for the research school is to provide an inspiring and ambitious environment for the stimulation of future research among junior scientists as well as the established seniors.
Courses established and available in autumn 2021:
Currently, the research school offers PhD- courses, which will run once a year in collaboration with Centre for Cancer Biomarkers – CCBIO.
CCBIONEURO 910: Patient and public involvement in medical and health research.
The aim of the course is to provide knowledge on how to involve user participations in clinical trials, and is conducted by Tone Skår, VIS, and Ass. Prof. Nina L. Jebsen. The first course is due 3.-5. November and attendees are awarded 2 ECTS.
CCBIONEURO 911: Clinical Trials in Cancer and Neurological diseases.
The course is designed to prepare the participants to accomplish clinical trials in humans, and is conducted by Prof. Øivind Grytten Torkildsen and Prof. Line Bjørge. The first course is due during 29. September to 1. October and attendees are awarded 2 ECTS.
CCBIONEURO 912: Health innovation.
The course will provide attendees with the necessary knowledge on how to succeed with innovation in health, and is conducted by Magnus Alvestad and Agnete Engelsen. The first course is due on the 8th and 9th of November and 2nd and 3rd of December, and attendees will be awarded 4 ECTS.
Who can participate in The Neuro-SysMed Research School in Translational Neuroscience?
The courses are open to researchers, postdocs, students (PhD, master, students in the Medical Student Research Program) and others who are interested, nationally and internationally
The research school is aiming at being inclusive and open also for ph.d- candidates who are not associated to the University of Bergen, by offering courses with opportunities for participating both in person and in virtual meetings.
An objective for the research school is also to provide the candidates an identity and a long- term benefit of being involved in Neuro-SysMed. A formal enrollment at the research school will strengthen networking and interactional skills in a scientific environment – being out most important for future research careers.